The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
about
Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Functional genomics lead to new therapies in follicular lymphomaEph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiationEphA7 regulates spiral ganglion innervation of cochlear hair cells.Nature and importance of follicular lymphoma precursors.Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategiesMining the cancer genome uncovers therapeutic activity of EphA7 against lymphoma.Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapyThe genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation.A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.Generation and characterization of a single-chain anti-EphA2 antibodyMutations in early follicular lymphoma progenitors are associated with suppressed antigen presentationThe putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis.EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaSynergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal ResistanceStromal cell contribution to human follicular lymphoma pathogenesis.Secreted Ephrin Receptor A7 Promotes Somatic Cell Reprogramming by Inducing ERK Activity ReductionPathogenesis of follicular lymphomaSheddomeDB: the ectodomain shedding database for membrane-bound shed markers.Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersComprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapiesEph receptor signaling and ephrinsThin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations.Parcellation of the thalamus into distinct nuclei reflects EphA expression and function.EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival.Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinomaVariability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.Eph-dependent cell-cell adhesion and segregation in development and cancer.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Regulation and misregulation of Eph/ephrin expression.'Til Eph do us part': intercellular signaling via Eph receptors and ephrin ligands guides cerebral cortical development from birth through maturation.Progress against follicular lymphoma
P2860
Q26779702-3B819E73-69C5-4047-A9F7-914C8E7AB158Q26852415-9E80C52A-FCF3-4EC3-9CE7-6EED907EB649Q27014166-448BAC07-B757-460E-9696-12EDD95E0FFCQ30359723-F83BE271-9548-487F-B402-432BF69D72F2Q33558757-70FF7BB2-9686-4D99-A9D2-12D0E028021AQ33622342-46100F1A-36BC-4BF5-B5A8-6A5C10ED82BDQ33674238-536B6891-C426-451E-A541-E10E0702D594Q33875566-A21C8F38-BAFB-4B2F-B01C-CBFE16946865Q33897503-DEA33618-DECE-4B10-B0F2-85E824C62F2AQ34256273-FC30CE5D-F3CB-4DE0-9300-BD2AA5F36F11Q34423830-AFF6CB15-882F-405B-814B-17CDC2D2E945Q34429176-A4C4D222-A83F-4F95-9BF7-464382420D99Q34493999-7666FD27-8563-42AD-ABFA-FE1862066B51Q34581396-E1E6503C-B21A-43A9-A11A-B3B127906E59Q35084573-5E528EFF-B3EC-4C39-B2F9-8F53C279803EQ35105377-6C690208-7CC5-49D9-B8D2-C9E6473633C7Q35189915-7CFE80E1-9416-4DEB-9D1D-FFD2AC6A12C4Q35237736-B3255FE4-CD93-455A-95E5-FAA86CD8F4C1Q35666005-ADDA975E-6606-4646-A95A-660BFFC77678Q35920657-A7FF26B4-CD18-439A-A359-2FDB1EB161F5Q35983871-5CC6CBCB-3F59-487A-9589-E73798BFF807Q36022154-DB1B9E5B-9B6A-4FE4-A452-8ACE5FE5B84BQ36208267-FAB5DFA5-AFFB-48EA-8B11-88210D89AE94Q36221307-C123104D-B19A-4352-A632-D48B254BAAD8Q36290288-CE246891-00E9-4527-9414-DC637982384CQ36329547-A249F877-4440-49EA-9A89-0855E6A24C7BQ37037246-69C2F68F-5C91-4557-B546-6BEDD0117EE0Q37047704-86F82275-5D65-4976-9129-8CC1DAD9FF71Q37122330-C2B9C0B5-64D4-46D1-8EDA-F064CA165658Q37327493-2E6B2ED8-9379-469F-9944-C267FB438791Q37339004-918CDA68-0825-4ACE-9620-195F7A991EBAQ37350976-2A85C0B3-6331-4333-85B0-FF8D929F49E0Q37452286-FA6E83EC-769E-45C3-BFEC-27115B71E25BQ37452434-997034C1-5DFE-461F-BD46-74C1A8F06DABQ37636976-754BE50A-E919-419A-8EFA-178A643EF503Q37971902-CFD44330-6718-4844-BEE5-974F6653E78FQ38006838-882985F4-B9FD-4E3E-81AB-7F3BCC862CD9Q38008491-51BC0AAE-F9A4-4601-A457-668677A89B7DQ38022537-AC9CF9E1-66D0-4ECB-8C21-2ED471DE50BBQ38106809-E6679F3D-ACCD-4358-972C-D3722984CA62
P2860
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@ast
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@en
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@en-gb
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@nl
type
label
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@ast
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@en
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@en-gb
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@nl
prefLabel
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@ast
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@en
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@en-gb
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@nl
P2093
P2860
P3181
P1433
P1476
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
@en
P2093
Adam B Olshen
Adriana Heguy
Andrew L Wolfe
Ari Melnick
Elisa Oricchio
Frances Weis-Garcia
Gouri Nanjangud
Hans-Guido Wendel
Joanne Bruno
Jonathan H Schatz
P2860
P304
P3181
P356
10.1016/J.CELL.2011.09.035
P407
P577
2011-10-28T00:00:00Z